Manufacturer Perspective on Sizing Guidance
Manufacturers must take a particularly cautious and conservative approach when providing sizing guidance for breast shields. Unlike healthcare professionals, who can directly assess individual anatomy and breast shield fit in real time, manufacturers rely on generalized instructions intended for a broad and diverse user population. As such, guidance must prioritize safety and risk mitigation across a wide range of real world use scenarios, including situations where no clinical support is available.
In addition, manufacturers are responsible for ongoing post market surveillance, which includes monitoring product performance, evaluating user feedback and complaints, and identifying potential safety concerns associated with product use. Within this context, reports in the literature have described adverse outcomes such as nipple trauma, blocked ducts, and mastitis associated with inappropriate breast shield sizing, particularly when shields are undersized. These findings, supported by peer reviewed evidence, reinforce the importance of clear, precautionary sizing recommendations and comprehensive user guidance as part of ensuring safe and effective product use.2,3
Anatomical Foundation: The Lactating Breast Under Ultrasound
The evidence base for breast shield fit begins with anatomy. Foundational work by Professor Donna Geddes and colleagues at The University of Western Australia used high-resolution ultrasound to characterize the lactating breast in vivo, providing insight not available from cadaveric studies.4 These studies demonstrate that milk ducts are superficial, located within a few millimeters of the skin surface, with a mean diameter of approximately 1.9 to 2.0 mm, and are readily compressible under external pressure.4 This structural feature underpins the risk associated with constrictive shield fit.
Ductal diameter increases by more than 50% during milk ejection, driven by oxytocin-mediated contraction.5,6 As a result, a shield that appears adequately sized at rest may impose meaningful compression during active pumping if expansion is not accommodated, particularly across the duration of milk flow. In parallel, the nipple undergoes measurable and dynamic expansion during pumping, increasing on average by approximately 2–3 mm in both diameter and length, with considerable inter-individual variability.7–9 This physiological change provides a key basis for the +4 mm starting point, which allows for tissue expansion under vacuum conditions.
Together, these findings show that the lactating breast changes dynamically during pumping, particularly across the duration of milk flow. A tunnel sized to closely match the nipple at rest may become functionally restrictive once vacuum is applied. Effective sizing must therefore account for dynamic tissue behavior during pumping.
Additional variability is observed in individuals with highly elastic tissue, where breast tissue may extend into and occupy the flange tunnel during pumping. This phenomenon can only be identified during an active session. While prevalence is not well established, internal estimates suggest it may occur in approximately 4% of mothers. Management strategies are variable and include smaller or larger flange sizes and alternative shield designs, with no single approach consistently effective.7 These cases further emphasize the importance of observation and individualized adjustment.
Clinical Harms of Constrictive Shield Fit
The clinical effects of undersized breast shields are well described and fall into three related categories.
Nipple Trauma and Tissue Injury
Contact between the nipple and tunnel wall during suction creates friction, leading to discomfort, erythema, abrasion, and tissue breakdown.2 Disruption of the epithelial barrier increases susceptibility to bacterial colonization and dysbiosis.10
Ductal Compression and Impaired Milk Removal
When the tunnel is too small, ducts may be compressed during suction, resulting in incomplete breast emptying and milk stasis.2,11 This activates feedback inhibitor of lactation pathways, leading to reduced milk synthesis over time.12,13 Importantly, raw expressed volume, especially when not tracked frequently, is an inadequate measure of this effect. It is well established in the literature that milk removal is most accurately assessed using Percentage of Available Milk Removed (PAMR), rather than expressed volume alone, due to variation in storage capacity across individuals.14,15 Studies relying solely on volume do not fully capture functional drainage.1
As a result, a mother with high storage capacity may express a volume that appears adequate, while still achieving a low PAMR, indicating compromised effectiveness of milk removal.14 Measures based on volume alone do not reliably reflect functional drainage, as stated by Anders, Mesite Frem and McCoy15 who note this limitation of their study and highlight that studies evaluating breast shield sizing based solely on expressed volume cannot adequately characterize milk removal. They suggest that in the future “researchers should consider measuring the percentage of available milk removed to represent these outcomes more accurately” (p. 8).
Mastitis
Milk stasis is a recognized upstream precondition for the inflammatory cascade that produces mastitis. The Academy of Breastfeeding Medicine Clinical Protocol #36 identifies incomplete milk removal as a contributing factor to ductal narrowing and breast inflammation.16 Mitoulas and Davanzo further describe the mechanistic link between impaired pump drainage and mastitis risk, noting that adequate milk removal is the critical protective factor.10 An undersized shield that impairs drainage on a repeated, session-by-session basis increases the likelihood of milk stasis and represents a modifiable risk factor.
Basis for the 4 mm Threshold
The 4 mm clearance is not a proprietary standard, but a commonly used operationalized sizing approach in the peer-reviewed pumping literature.11,17–21. It provides a reproducible baseline for study conditions, where sizing must be standardized based on static measurements prior to pumping, without accounting for dynamic tissue behavior. As such, it controls for fit-related variability rather than defining optimal individual fit, which may differ in practice, and it serves as a standardized method for selecting shield size in research settings.
In their randomized controlled non-inferiority trial, Sakalidis and colleagues11 selected shield sizes using an explicit 4 mm rule: "The selected shield tunnel diameter for each breast was at least 4 mm larger than the nipple diameter to allow for nipple expansion during pumping" (p. 1563). This clearance directly accounts for the dynamic nipple expansion that occurs under negative pressure during pumping.
Coentro and colleagues, in a mechanistic study conducted within the Geddes laboratory, used the same threshold to define correct fit: shield diameter greater than or equal to 4 mm above nipple diameter.22 Their study also defined a "small shield" condition as less than 4 mm clearance and found that sessions using this condition were associated with compromised milk removal, with PAMR as the primary effectiveness measure. The 4 mm threshold is therefore both the operationalized standard in this body of research and the boundary below which harm risk increases.
Importantly, this threshold aligns closely with the observed average nipple expansion of approximately 2–3 mm during pumping, while also providing an additional margin to accommodate inter-individual variability, measurement variation, and ductal expansion occurring concurrently.7–9 The +4 mm starting point therefore reflects not a single anatomical parameter, but the combined physiological requirements of the lactating breast: space for nipple expansion, protection against ductal compression, and a safety margin that supports effective and comfortable milk removal across a diverse population.
Interpreting Comfort and Preference Data
Individual variability in fit experience is well documented, and the literature includes reports of mothers expressing comfort preference for both closer- and looser-fitting shields.1 This variability is expected given differences in anatomy, tissue characteristics, and prior experience with pumping. It does not contradict the need for a standardized, evidence-based starting point, but rather underscores the role of clinical judgment in refining fit.
From a clinical standpoint, comfort and effectiveness are distinct constructs. Subjective comfort does not reliably reflect ductal function or adequacy of milk removal. A mother may report acceptable comfort while compression is occurring below the threshold of perceived discomfort, particularly in the early postpartum period when nipple sensitivity varies widely and no prior pumping baseline exists for comparison. In this context, comfort alone is not a sufficient indicator of appropriate fit.
As discussed, effective milk removal is best evaluated using Percentage of Available Milk Removed (PAMR), which accounts for variation in breast storage capacity and provides a more accurate measure of functional drainage.14,22 Reliance on expressed volume or subjective comfort may fail to detect compromised milk removal, particularly when constrictive fit limits ductal flow without producing immediate or noticeable discomfort. This consideration is particularly important in high-risk populations, including mothers who rely predominantly on expression for milk provision, where compromised drainage may have direct implications for both maternal and infant outcomes.23,24 In these settings, simplified approaches to sizing that prioritize comfort alone may result in suboptimal or unsafe fit.
The Role of Clinical Assessment
Medela's ‘Room to Move’ approach with a +4 mm starting point is a clinical floor, not a clinical endpoint. It reflects the minimum safe margin supported by the evidence. From that starting point, a qualified clinician is positioned to individualize fit based on direct observation.
Effective clinical sizing requires watching nipple and areolar movement during active pumping at the mother's maximum comfortable vacuum, assessing for blanching, tunnel wall contact, excessive areolar draw-in, and signs of incomplete emptying. Nipple diameter measurement alone, without observational assessment during pumping, is insufficient for full individualization. This clinical judgment cannot be replaced by manufacturer guidance, and it is what distinguishes expert clinical sizing from a written recommendation.
Summary
A breast shield tunnel diameter up to 4 mm above measured nipple diameter reflects established physiological expansion during pumping. +4 mm is the threshold used in peer-reviewed research to define appropriate fit and avoid ductal compression, impaired drainage, and tissue injury. For these reasons this evidence satisfies Medela’s obligation to avoid known harm patterns.
This starting point does not replace individualized clinical care. A skilled lactation professional should observe the mother during an entire pumping session to conduct a comprehensive breast and pumping assessment, incorporating nipple and areola dynamics, maximum comfortable vacuum, maternal comfort and milk expression effectiveness. Clinicians are encouraged to assess fit directly and adjust as clinically warranted. For mothers without access to clinical support, the +4 mm starting point provides a safe, evidence-based starting point for effective use.
Additional information
Finding the right breast shield: Key to comfortable and effective pumping
'Room to Move': A Step-by-Step Guide to Find Your Breast Shield Size
